Brustkrebs Illustrationen

Zurück zur Übersicht

Erklärvideo zu den Brustkrebs Illustrationen

Pathology & Histology

Pathology & Histology_ER and PR expression

Pathology & Histology_HER2 testing

Pathology & Histology_Prevalence of HER2-low

Antibody Drug Conjugates

ADC_Circulation

ADC_Linker Stability

ADC_Milestones in ADC payload development

ADC_Molecular components of ADCs

ADC_Rationale for ADC-based combination therapies

ADC_Sacituzumab Govitecan

ADC_Timeline History

Trop-2

Trop2_Domain Organization

Trop2_Trop-2 overexpression in cancer

Trop2_Trop-2 Signaling

MoA - Mode of Action

Mode of Action_Antibody Drug Conjugate

Mode of Action_Capecitabine

Mode of Action_Capivasertib

Mode of Action_Cdk4-6 Inhibitors

Mode of Action_Combination of targeted therapies and antiestrogen theraies

Mode of Action_Doxorubicin

Mode of Action_ER targeted therapy

Mode of Action_Eribulin

Mode of Action_Gemcitabine

Mode of Action_HER-2 targeted therapy

Mode of Action_Hormone therapies

Mode of Action_Immune checkpoint inhibitors

Mode of Action_PARP Inhibitors

Mode of Action_PD(L)-1 Inhibitors

Mode of Action_Sacituzumab Govitecan

Mode of Action_Taxane

Mode of Action_Topoisomerase 1 inhibition

Facts & Figures

Facts and Figures_Breast cancer histological subtypes

Facts and Figures_Breast cancer intrinsic subtypes

Facts and Figures_Breast cancer US numbers

Facts and Figures_Common metastatic sites in breast cancer

Facts and Figures_Common side effects in breast cancer treatment

Facts and Figures_Tumor localization by frequency and sex AUT numbers

Facts and Figures_Tumor localization by frequency and sex US numbers